Optinose ( (OPTN) ) has released its Q3 earnings. Here is a breakdown of the information Optinose presented to its investors. Optinose is a ...
Amsellem covers the Healthcare sector, focusing on stocks such as Alkermes, Supernus Pharmaceuticals, and Corcept Therapeutics. Optinose has an analyst consensus of Moderate Buy, with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback